Specifically, two subsets of CAFs in HNSCC emerged as predictive of nivolumab response and were found to reduce TGF-β-dependent PD-1+/TIM-3+ exhaustion of CD8 T cells and enhance the overall cytolytic profile of T cells [26]. This evidence concerns the gene TGFB1 and head and neck squamous cell carcinoma.